|
Business
Capital Gazette Communications
Published
05/11/08
Last year, David Wright, president of Annapolis-based biodefense firm PharmAthene, flew into the Durham Tees Valley Airport to meet with senior officials from a United Kingdom company called Avecia. 
Courtesy photoFind Us On Facebook
After several trips and months of negotiation, Mr. Wright wooed Avecia to the table in a deal that allows PharmAthene to purchase the rights to develop the company's anthrax vaccines, now deep in the development stages.
Last month, PharmAthene closed on a $40 million deal with the United Kingdom company, building up its biodefense portfolio in the works since 2001. Now, the Annapolis company hopes Avecia's vaccines will help...
Copyright © Capital Gazette Communications LLC, 2012.
See our Privacy Policy and Terms of Use |
| #1 - English county's official language? (17 comments) |
| #2 - Animal Control: Injured pit bull used as 'bait dog' (12 comments) |
| #3 - Right Stuff: Judge O'Malley's decision (12 comments) |
| #4 - Anne Arundel cracks down on land use offenses (7 comments) |
| #5 - Bates gets $1M grant for gym, theater (7 comments) |
|
If you encounter other problems, please email nlundskow@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.
In order to post or vote on a comment, you must be signed in with a hometownannapolis account.
Take a look at a summary of Commenting Guidelines.
If you encounter other problems, please email nlundskow@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.